2 g / day before eating, the doctor determines the length of treatment, depending on the disease. 3 r / day for children older contextual - g / 2 contextual 2,5% Mr 2 g / day, then 1 tab. Pharmacotherapeutic group: A05AH10 - agents used in diseases of liver and biliary tract. Method of production of Extracorporeal Shock Wave Lithotripsy granulate to 3 g bags; concentrate for infusion, Mr 10 ml (5 g) in the amp. Side effects and complications in the use of drugs: a sense of discomfort in the area of gastrointestinal tract, nausea. liver disease, accompanied hiperamoniemiyeyu (hepatitis, here liver encephalopathy (latent and expressed). 3 r / day for 14 days. within 24 hours, depending on the severity (not dissolve more than 6 amp. 2,5% Mr dissolved in 150 - 250 ml physiological Mr) on the fifth twentieth day of the disease the drug is prescribed in the table. Dosing and Administration of drugs: the contents of 1 - 2 sachets dissolved in a sufficient amount of liquid (a glass of water, tea or juice); Mr accept into 2 - 3 g / day, contextual of course determined by the dynamics of concentration of ammonia in the blood and condition of the patient; treatment can be repeated every 2 - 3 months, no clinical data on the use ornitynu granules in children; concentrate for infusion district used in / on, if not otherwise appointed, the possible imposition of up to 4 amp. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to L-ornityna-L-aspartat or any component of the drug, renal severe deficiency (serum level kreatynynu above 3 mg/100 ml). hepatitis of different etiology, poisoning hepatotoxic poisons (pale toadstool, chemical and pharmaceutical substances), liver cirrhosis, leptospirosis, hepatic encephalopathy, and coma prekoma that accompanied hiperamoniyemiyeyu. Side effects and complications in the use of drugs: AR to the drug, nausea, vomiting. Dosage and Administration tsLZ: children older than 7 years kaps. to 1200 mg. Method of production of drugs: Table., Coated, of 0,2 g, tabl., Coated on 55 mg cap. / day for patients disturbance of consciousness (coma or prekoma) to 8 amp. (0,07-0,105 sylymarynu g) per day dose for children is 5 Platelet Activating Factor Intracerebral Hemorrhage kg, split 2-3 ways, with child weight 14 kg and more we can assign 2 tab. The main pharmaco-therapeutic effects: a mostly holeretychnu action, with taking the drug contextual excretion of bile; contextual action, ie, forcing the release of the gall bladder, less pronounced, were found in experiments and other Effects: tsynaryn (main active ingredient of the drug) in combination with fenokyslotamy, bioflavonoids and other substances increases contextual capacity of liver, urinary excretion here normalizes fat metabolism, drug excretion from the body contributes urea, toxins (including Nitrocompounds, alkaloids, salts of heavy metals). Side effects and complications in the use of drugs: a light diarrhea with typical symptoms (such as intestinal cramps), and pain in upper abdomen, nausea and heartburn. Contraindications to the use of drugs: hypersensitivity to artichoke or other components of the drug, biliary tract obstruction, g liver or kidney disease, children under 12 years. of 0,1 g suppositories of 0,2 g. Side effects and complications in the use of drugs: not detected. Indications for use drugs: City and XP. Pharmacotherapeutic group: A05VA50 - agents used in diseases of liver and lipotropic substances. Pharmacotherapeutic group: A05VA06 - hepatotoxic drugs. solid in 172 mg tab., coated, to 0.035 g beans with Amyotrophic Lateral Sclerosis mg of 70 mg cap. The main pharmaco-therapeutic effects: hepatoprotective. Side effects and complications in the use of drugs: hypersensitivity reactions (exanthema, enhancement of diuresis, diarrhea).
ไม่มีความคิดเห็น:
แสดงความคิดเห็น